Drug
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, And Amphetamine Sulfate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Inability To Afford Medication | 43 | 106.7 | 112.3 | signal |
| 2 | Insurance Issue | 37 | 60.7 | 63.3 | signal |
| 3 | Product Availability Issue | 45 | 48.9 | 51.5 | signal |
| 4 | Product Physical Issue | 19 | 23.2 | 23.7 | signal |
| 5 | Therapeutic Response Shortened | 21 | 16.0 | 16.4 | signal |
| 6 | Disturbance In Attention | 31 | 13.9 | 14.4 | signal |
| 7 | Drug Effect Less Than Expected | 8 | 13.8 | 13.9 | signal |
| 8 | Bipolar Disorder | 5 | 11.1 | 11.2 | signal |
| 9 | Middle Insomnia | 8 | 10.5 | 10.5 | signal |
| 10 | Feeling Jittery | 8 | 10.2 | 10.3 | signal |
| 11 | Initial Insomnia | 4 | 9.5 | 9.6 | signal |
| 12 | Euphoric Mood | 4 | 9.4 | 9.5 | signal |
| 13 | Anger | 13 | 9.3 | 9.4 | signal |
| 14 | Irritability | 21 | 8.5 | 8.7 | signal |
| 15 | Sexual Dysfunction | 4 | 8.3 | 8.4 | signal |
| 16 | Therapeutic Product Effect Decreased | 15 | 8.2 | 8.3 | signal |
| 17 | Intentional Dose Omission | 9 | 8.0 | 8.1 | signal |
| 18 | Hereditary Angioedema | 3 | 6.9 | 7.0 | signal |
| 19 | Sedation | 7 | 6.5 | 6.6 | signal |
| 20 | No Adverse Event | 45 | 6.2 | 6.5 | signal |
| 21 | Withdrawal Syndrome | 10 | 5.8 | 5.8 | signal |
| 22 | Drug Effect Decreased | 9 | 4.0 | 4.0 | signal |